Welcome to Medivirs R

1
Welcome to Medivirs RD-day, 22 November 2pm-5pm

• Welcome Rein Piir,CFO/IR Medivir AB
• Selling and marketing pharmaceuticals
• in the Nordic region Stefan Mårtensson, VP
  Sales Marketing
• Medivirs late preclinical projects Bertil
  Samuelsson, VP Discovery Research
• Medivirs clinical projects an overview
  Börje Darpö, VP Development
• Lipsovir (cold sores) Eva Arlander,
  Director of Clinical Research
• Coffee Break
• Medivir HIV Franchise
• milestones during the year Bo Öberg, CEO
  Medivir HIV Franchise
• MIV-701 (bone disorders) Börje Darpö, VP
  Development
• Hepatitis C the silent killer Börje Darpö,
  VP Development
• TMC435350 (hepatitis C virus) Bertil
  Samuelsson, VP Discovery Research
• Business model and RD day summary Lars
  Adlersson, CEO Medivir AB
• Questions, conclusions refreshments